Company Announcements: (reported by the Company) |
No items found
|
|
Elevator Pitch: | Eyetelligence Ltd is a TGA-approved AI-based clinical decision support software for optometrists. Our software is a clinically-validated convolutional neural network that has been trained using over 200,000 real-world cases including various ethnicities to detects signs of glaucoma, age-related macular degeneration and diabetic retinopathy from colour fundus photographs with an accuracy of 95%. The software utilises existing practice hardware, fits into existing workflow and shows results in seconds. It’s just like having a second opinion from your own in-house ophthalmologist, helping you make better clinical decisions to provide the highest level of patient care. Developed by world-leading ophthalmologic experts in conjunction with CERA (Centre for Eye Research Australia) and Monash University, the software has been 7 years in the making supported by several government research grants. The accuracy data and validation has been published by collaborators in prestigious journals. |
|
Category: | AI, Health & biotech | |
URL: | https://eyetelligence.com.au | |
Operational Status: | Active | |
ASX Listing Code (if applicable): | ||
Year of Commencement: | 2019 | |
Address: | Melbourne, AU |
|
State: | Victoria | |
Overseas Operations: | No | |
Twitter: | ||
Facebook: | ||
Linkedin: | https://linkedin.com/company/eyetelligence-assure | |
Founders: | ||
Awards won: | ||